...
首页> 外文期刊>Alcoholism: Clinical and experimental research >Involvement of dopamine D2 autoreceptors in the ventral tegmental area on alcohol and saccharin intake of the alcohol-preferring P rat.
【24h】

Involvement of dopamine D2 autoreceptors in the ventral tegmental area on alcohol and saccharin intake of the alcohol-preferring P rat.

机译:多巴胺D2自体受体在腹侧被盖区与嗜醇P大鼠的酒精和糖精摄入有关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The ventral tegmental area (VTA) dopamine (DA) system is considered to be involved in mediating the actions of ethanol (EtOH). The objective of the present study was to examine the role of VTA DA D2 receptors in regulating EtOH intake of alcohol-preferring P rats. METHODS: EtOH (10% v/v) and saccharin (SACC, 0.0125% g/v) intake during 2 hr of limited access was assessed after microinjections of the D2 agonist quinpirole and the D2 antagonist sulpiride into the anterior VTA (AVTA) of female P rats. Both EtOH-SACC alternate-day-access conditions and daily availability of EtOH and SACC solutions to separate groups of subjects were used. A second D2 agonist, quinelorane, and coadministration of 2.0 microg sulpiride with 2.0 microg quinpirole were tested in animals given limited access to EtOH. Finally, the effects of quinpirole injected 2 mm dorsal to the VTA and within the posterior VTA (PVTA) were assessed under EtOH-SACC alternate-day-access conditions. RESULTS: Microinjections of 2.0-6.0 microg quinpirole into the AVTA dose dependently decreased EtOH intake 40-80% during the first 30 min of the limited access sessions but did not alter SACC intake. Injections of 2.0-4.0 microg quinelorane into the AVTA also reduced EtOH intake in the first 30 min. Administration of 0.5-2.0 microg sulpiride into the AVTA had no effect on either EtOH or SACC intakes but did attenuate the effects of quinpirole on reducing EtOH intake. Injections of 2.0-4.0 quinpirole 2 mm dorsal to the VTA did not alter EtOH or SACC intakes. Posterior VTA injections of quinpirole decreased EtOH and SACC intakes approximately 25-30% and 60-70%, respectively, in the first 30 min. None of the treatments altered intakes during the 30-120 min period. CONCLUSIONS: The data suggest that DA neuronal activity within the AVTA may be important for maintaining EtOH drinking in P rats, whereas DA neuronal activity within the PVTA may be involved in regulating general drinking and/or motivational behaviors. Overall, the results confirm the involvement of mesolimbic DA in EtOH self-administration and suggest that there is functional heterogeneity within the VTA regulating drinking behavior of the P rat.
机译:背景:腹侧被盖区(VTA)多巴胺(DA)系统被认为与介导乙醇(EtOH)的作用有关。本研究的目的是研究VTA DA D2受体在调节酒精偏爱的P大鼠的EtOH摄入中的作用。方法:在将D2激动剂喹吡罗和D2拮抗剂舒必利微注射到大鼠前VTA(AVTA)中后,评估了2小时有限访问期间的EtOH(10%v / v)和糖精(SACC,0.0125%g / v)的摄入量。雌性P大鼠。同时使用了EtOH-SACC隔日访问条件以及EtOH和SACC溶液分别对不同组受试者的每日可用性。在限制接触EtOH的动物中测试了第二种D2激动剂喹诺罗烷,以及2.0微克舒必利和2.0微克喹吡罗的共同给药。最后,在EtOH-SACC隔日访问条件下评估了喹吡罗在VTA背侧2 mm注射和后VTA(PVTA)内的作用。结果:在有限访问时段的前30分钟内,向AVTA剂量微注射2.0-6.0微克喹吡酮可减少40-80%的EtOH摄入量,但不会改变SACC摄入量。在前30分钟内,向AVTA中注射2.0-4.0 microg喹诺烷也减少了EtOH的摄入。在AVTA中施用0.5-2.0微克舒必利对EtOH或SACC摄入量均无影响,但确实减弱了喹吡罗对减少EtOH摄入量的影响。向VTA背侧注射2.0-4.0喹吡罗2毫米,未改变EtOH或SACC摄入量。在最初的30分钟内,后VTA注射喹吡罗可分别降低EtOH和SACC摄入量约25-30%和60-70%。在30-120分钟内,所有治疗均未改变摄入量。结论:数据表明,AVTA内的DA神经元活性对于维持P大鼠的EtOH饮用可能很重要,而PVTA内的DA神经元活性可能与调节一般饮酒和/或动机行为有关。总的来说,这些结果证实了中脑边缘DA参与EtOH自我管理,并表明VTA内有功能异质性调节P大鼠的饮酒行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号